NCT03166930

Brief Summary

This study will examine the impacts of two different methods of managing MS-related spasticity of the lower limbs. Both interventions will be presented via video teleconference in group classes consisting of exercises to reduce spasticity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 25, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
4.1 years until next milestone

Results Posted

Study results publicly available

March 11, 2026

Completed
Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

3.6 years

First QC Date

May 19, 2017

Results QC Date

January 22, 2026

Last Update Submit

March 9, 2026

Conditions

Keywords

Muscle SpasticityMuscle Stretching Exercises

Outcome Measures

Primary Outcomes (2)

  • Impact of Spasticity, Measured by the Multiple Sclerosis Spasticity Scale-88

    Impact of spasticity will be measured using the Multiple Sclerosis Spasticity Scale-88 at one month post intervention. Minimum score = 88. Maximum score = 352. A higher score is a worse outcome.

    One month post-intervention

  • Impact of Spasticity, Measured by the Multiple Sclerosis Spasticity Scale-88

    Impact of spasticity will be measured using the Multiple Sclerosis Spasticity Scale-88 at six months post intervention. Minimum score = 88. Maximum score = 352. A higher score is a worse outcome.

    Six months post-intervention

Secondary Outcomes (8)

  • Severity of Spasticity, Measured by the Numeric Rating Scale for Spasticity

    One month post-intervention

  • Fatigue, Measured by the Modified Fatigue Impact Scale

    One month post-intervention

  • Sleep Quality and Quantity, Measured by the Pittsburgh Sleep Quality Index

    One month post-intervention

  • Psychological and Physical Impact on Day-to-day Life, Measured by the Multiple Sclerosis Impact Scale-29 (MSIS-29)

    One month post-intervention

  • PROMIS Item Bank v1.0 - Emotional Distress - Depression-Short Form 8a

    One month post-intervention

  • +3 more secondary outcomes

Study Arms (2)

Spasticity Take Control

EXPERIMENTAL

Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and a stretching program for spasticity management.

Behavioral: Spasticity Take Control

Stretching for People with MS: An Illustrated Manual

ACTIVE COMPARATOR

Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and exercises for spasticity management.

Behavioral: Stretching for People with MS: An Illustrated Manual

Interventions

Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and a stretching program for spasticity management.

Spasticity Take Control

Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and exercises for spasticity management from the manual.

Stretching for People with MS: An Illustrated Manual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of definite MS by 2010 updated McDonald Criteria
  • Age 18 or older
  • Able to walk 25 feet with any assistive devices (Patient Determined Disease Steps 0-6)
  • Fluent in written and spoken English, as materials are not validated in languages other than English.
  • Presence of self-reported lower extremity spasticity that is interfering with daily activities or sleep, using the this definition: Have spasticity in your legs with unusual tightening of muscles that feels like leg stiffness, jumping of the legs, a repetitive bouncing of the foot, muscle cramping in the legs, or the legs going out tight and straight or drawing up.
  • All women that meet the above criteria
  • Only Veteran men that meet the above criteria

You may not qualify if:

  • Any uncontrolled medical or mental condition that would limit participation or completion of the study
  • Any self-reported musculoskeletal or neurological condition other than MS that is known to cause spasticity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Portland Health Care System, Portland, OR

Portland, Oregon, 97239, United States

Location

Related Publications (1)

  • Hugos CL, Cameron MH. MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial. BMC Neurol. 2020 Oct 7;20(1):368. doi: 10.1186/s12883-020-01902-1.

MeSH Terms

Conditions

Multiple SclerosisMuscle Spasticity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Cinda Hugos
Organization
VAPORHCS

Study Officials

  • Lucinda L. Hugos, PT MS

    VA Portland Health Care System, Portland, OR

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomized to receive one of two exercise programs. Participants will not be masked regarding which group they are in, but they will not be told which group is considered standard of care and which is the intervention.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2017

First Posted

May 25, 2017

Study Start

January 1, 2018

Primary Completion

July 30, 2021

Study Completion

January 31, 2022

Last Updated

March 11, 2026

Results First Posted

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations